March 16, 2015 / 12:17 PM / 2 years ago

Valeant raises offer for Salix Pharma to $173 per share

March 16 (Reuters) - Valeant Pharmaceuticals International Inc said it increased its offer for Salix Pharmaceuticals Inc to $173 per share, hoping to end a bidding war with Endo International Plc for the bowel drug maker.

Valeant agreed to buy Salix last month for $158 per share in cash. Endo then offered about $175 per share in cash and stock for Salix last week.

Valeant's new offer provides Salix stockholders with an about $1 billion more in cash, Valeant said on Monday. (Reporting by Ankur Banerjee in Bengaluru; Editing by Savio D'Souza)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below